Kliničke studije za HIV u državi Texas
23 studija za HIV traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Abounding Prosperity Inc., Dallas
- Prism Health, Dallas
- UT Health, Houston
- i još 1
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, Dallas
- i još 2
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07650916ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- Baylor College of Medicine, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06274632A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire
- Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
- Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
- i još 1
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT07266831Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
U tijeku regrutacijaFaza 1/2
48 Hours · Oba spola · Ažurirano 9. ruj 2026. · NCT02140255Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- M D Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 4. ruj 2026. · NCT02479698A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
- The Crofoot Research Center, Houston
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 50 godina · Oba spola · Ažurirano 21. kol 2026. · NCT07698600Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- University of Texas M.D. Anderson Cancer Center, Houston
U tijeku regrutacija
Od 45 do 80 godina · Oba spola · Ažurirano 19. kol 2026. · NCT04949464Positive Peers Intervention Clinical Trial
- Thomas Street Clinic, Houston
U tijeku regrutacija
Od 13 do 34 godina · Oba spola · Ažurirano 18. kol 2026. · NCT06388109Screen2Prevent (S2P)
- Baylor College of Medicine, Houston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 14 do 24 godina · Oba spola · Ažurirano 17. kol 2026. · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- North Texas Infectious Diseases Consultants, P.A., Dallas
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT07682961First Time in Human Study of Long Acting VH4524184 Formulations
- GSK Investigational Site, San Antonio
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 10. kol 2026. · NCT06310551A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- UT Health Houston, Houston
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. srp 2026. · NCT07143968A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Bellaire
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- i još 2
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. srp 2026. · NCT07202546Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Houston Methodist Research Institute, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 22. lip 2026. · NCT06263426Menopausal HT for Women Living With HIV (HoT)
- Houston AIDS Research Team CRS (31473), Houston
U tijeku regrutacijaFaza 4
Od 40 do 60 godina · Žene · Ažurirano 22. svi 2026. · NCT06856174Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- The University of Texas Health Science Center at Houston, Houston
U tijeku regrutacija
Od 18 do 25 godina · Oba spola · Ažurirano 13. svi 2026. · NCT06074354HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- UT Southwestern Medical Center, Dallas
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 21. sij 2026. · NCT06659952The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 99 godina · Oba spola · Ažurirano 15. sij 2026. · NCT07292792A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- GSK Investigational Site, Austin
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 18. pro 2025. · NCT05418868Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- UT Health Houston, Houston
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT05488431A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- GSK Investigational Site, Austin
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 29. lis 2025. · NCT06724640Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
U tijeku regrutacijaFaza 1/2
Od 6 do 12 godina · Oba spola · Ažurirano 19. ruj 2024. · NCT05674656Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.